MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 30, Issue 5, Pages 682-697
Publisher
Springer Nature
Online
2017-01-13
DOI
10.1038/modpathol.2016.231
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry
- (2017) D. Craig Allred et al. Journal of the National Comprehensive Cancer Network
- Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value
- (2015) Shalaka Joshi et al. BMC CANCER
- Immunohistochemical Expression of MCM2 in Nonmelanoma Epithelial Skin Cancers
- (2014) Asmaa Gaber Abdou et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- MMP-9 expression varies according to molecular subtypes of breast cancer
- (2014) Einas M Yousef et al. BMC CANCER
- The UCSC Genome Browser database: 2015 update
- (2014) Kate R. Rosenbloom et al. NUCLEIC ACIDS RESEARCH
- Prognostic Value of Ki-67 in Breast Cancer Patients with Positive Axillary Lymph Nodes: A Retrospective Cohort Study
- (2014) Feng-yan Li et al. PLoS One
- Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma
- (2013) I. I. Wistuba et al. CLINICAL CANCER RESEARCH
- Cancer gene expression signatures – The rise and fall?
- (2013) Frederic Chibon EUROPEAN JOURNAL OF CANCER
- Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis
- (2013) Molly E Klein et al. MODERN PATHOLOGY
- Performance of an Automated Polysomnography Scoring System Versus Computer-Assisted Manual Scoring
- (2013) Atul Malhotra et al. SLEEP
- MCM-2 is a therapeutic target of Trichostatin A in colon cancer cells
- (2013) Yangbo Liu et al. TOXICOLOGY LETTERS
- bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses
- (2013) P. Jezequel et al. Database-The Journal of Biological Databases and Curation
- The current state of breast cancer classification
- (2012) G. Viale ANNALS OF ONCOLOGY
- Prognostic Value of Breast Cancer Subtypes, Ki-67 Proliferation Index, Age, and Pathologic Tumor Characteristics on Breast Cancer Survival in Caucasian Women
- (2012) N. Lynn Ferguson et al. Breast Journal
- Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
- (2012) H R Ali et al. BRITISH JOURNAL OF CANCER
- Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening
- (2012) A. Caldarella et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer
- (2012) Aleix Prat et al. JOURNAL OF CLINICAL ONCOLOGY
- High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients
- (2012) Shu Zhao et al. MEDICAL ONCOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Molecular Classification of Estrogen Receptor-positive/Luminal Breast Cancers
- (2011) Felipe C. Geyer et al. ADVANCES IN ANATOMIC PATHOLOGY
- Is the Ki-67 labelling index ready for clinical use?
- (2011) W. Jonat et al. ANNALS OF ONCOLOGY
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
- (2011) Jack Cuzick et al. LANCET ONCOLOGY
- Bimodal gene expression patterns in breast cancer
- (2010) Marina Bessarabova et al. BMC GENOMICS
- MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups
- (2010) Mohammed A. Aleskandarany et al. BREAST CANCER RESEARCH AND TREATMENT
- Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
- (2010) Andrzej Wojnar et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Value of Ki67 in breast cancer: the debate is still open
- (2010) Mariantonietta Colozza et al. LANCET ONCOLOGY
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- Gene signatures in hepatocellular carcinoma (HCC)
- (2010) Ourania M. Andrisani et al. SEMINARS IN CANCER BIOLOGY
- The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type
- (2009) Britta Weigelt et al. JOURNAL OF PATHOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Minichromosome maintenance protein 2 is a reliable proliferative marker in breast carcinoma
- (2008) Rahayu Md Zin Reena et al. Annals of Diagnostic Pathology
- Molecular Subtypes of Breast Cancers Detected in Mammography Screening and Outside of Screening
- (2008) H. Sihto et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started